Patent · US Active

Antibodies targeting glioblastoma stem-like cells and methods of use thereof

US11780932B2 · kind B2 · utility

0Cited by
0References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2018
Grant dateOct 10, 2023
Priority date—
Expiry dateApr 18, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides antibodies that target glioblastoma stem-like cells and methods and kits for their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.